RemeGen Co., Ltd. (REGMF)
USD 1.5
(0.0%)
USD 1.5
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 550.91 Million CNY | 127.97% |
| 2022 | -1.96 Billion CNY | -19.08% |
| 2021 | -1.65 Billion CNY | 35.66% |
| 2020 | -2.57 Billion CNY | -8441.7% |
| 2019 | 30.81 Million CNY | 5623.12% |
| 2018 | -558 Thousand CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 236.88 Million USD | 59.7% |
| 2024 Q3 | 259.31 Million USD | 8.47% |
| 2024 Q1 | 149.16 Million USD | 95.72% |
| 2023 Q3 | 32.47 Million USD | 107.77% |
| 2023 Q1 | -136.61 Million USD | 93.06% |
| 2023 FY | 550.91 Million CNY | 127.97% |
| 2023 Q4 | 74.79 Million USD | 130.32% |
| 2023 Q2 | -418.09 Million CNY | -206.03% |
| 2022 Q3 | -265.87 Million USD | 89.37% |
| 2022 Q2 | -2.5 Billion CNY | -339.6% |
| 2022 Q1 | -569.12 Million USD | 65.59% |
| 2022 FY | -1.96 Billion CNY | -19.08% |
| 2022 Q4 | -1.96 Billion CNY | -640.81% |
| 2021 Q1 | - USD | 100.0% |
| 2021 FY | -1.65 Billion CNY | 35.66% |
| 2021 Q4 | -1.65 Billion CNY | 0.0% |
| 2021 Q3 | - USD | 100.0% |
| 2021 Q2 | -1.4 Billion CNY | 0.0% |
| 2020 FY | -2.57 Billion CNY | -8441.7% |
| 2020 Q4 | -2.57 Billion CNY | 0.0% |
| 2020 Q2 | -48.42 Million CNY | 0.0% |
| 2019 FY | 30.81 Million CNY | 5623.12% |
| 2019 Q4 | 30.81 Million CNY | 0.0% |
| 2018 FY | -558 Thousand CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | -3394.957% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | -13278.018% |
| SQZ Biotechnologies Company | -36.23 Million USD | 1620.255% |
| Evofem Biosciences, Inc. | 42.79 Million USD | -1187.383% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | 8838.328% |
| Mesoblast Limited | 55.85 Million USD | -886.264% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | -59317.42% |
| Genus plc | 190.6 Million USD | -189.04% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | -24540.045% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | -45283.923% |
| Marizyme, Inc. | 18.56 Million USD | -2866.822% |
| ContraFect Corporation | -6.02 Million USD | 9242.217% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | -80916.176% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | -409075.647% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | -47580.126% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | -24469.704% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | -9913.094% |
| MultiCell Technologies, Inc. | 90.04 USD | -611850188.761% |
| Accustem Sciences Inc. | -733.97 Thousand USD | 75158.108% |
| RVL Pharmaceuticals plc | 12.94 Million USD | -4155.446% |
| EV Biologics, Inc. | 1.36 Million USD | -40172.053% |
| Q BioMed Inc. | 4.06 Million USD | -13469.185% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | -1703.07% |
| Neon Bloom, Inc. | 622.36 Thousand USD | -88418.937% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | -54569.173% |
| Biomind Labs Inc. | 711.4 Thousand USD | -77340.041% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 109.8 Million USD | -401.721% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | -4201.77% |
| Skye Bioscience, Inc. | -5.72 Million USD | 9728.955% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | -63941.356% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | -393958.825% |
| Arch Therapeutics, Inc. | 5.64 Million USD | -9653.433% |
| IMV Inc. | 7.67 Million USD | -7082.172% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | -2772890.386% |
| Curative Biotechnology, Inc. | 2.2 Million USD | -24918.835% |
| GB Sciences, Inc. | 1.74 Million USD | -31428.928% |
| Alpha Cognition Inc. | -183.78 Thousand USD | 299852.976% |
| HST Global, Inc. | 96.79 Thousand USD | -569063.059% |
| CSL Limited | 10.52 Billion USD | 94.766% |
| Halberd Corporation | 144.72 Thousand USD | -380570.393% |
| Enzolytics Inc. | 981.65 Thousand USD | -56020.474% |
| Resverlogix Corp. | 6.45 Million USD | -8439.916% |
| Affymax, Inc. | -5.59 Million USD | 9942.952% |
| SYBLEU INC | 473.71 Thousand USD | -116195.909% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | 81948.017% |
| argenx SE | -2.02 Billion USD | 127.154% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | -1168.384% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 1271.85% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -20239.177% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | 6332.076% |
| AVAX Technologies, Inc. | -5.9 Million USD | 9432.385% |
| Zenith Capital Corp. | 10.06 Thousand USD | -5473965.978% |
| Genscript Biotech Corporation | -1.06 Billion USD | 151.907% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | -274761.3% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | -22988.942% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | -334781.374% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | -809.907% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | -27453.876% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | -2.57 Million USD | 21535.92% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -153053.93% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.27 Million USD | -2617.055% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | 3007578.982% |
| BioStem Technologies, Inc. | 4.47 Million USD | -12219.066% |
| ONE Bio Corp. | 9.04 Million USD | -5994.114% |
| Reve Technologies, Inc. | 201.25 Thousand USD | -273638.659% |
| Burzynski Research Institute, Inc. | -1310.00 USD | 42054298.473% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | -267050.623% |
| Agentix Corp. | 37.63 Thousand USD | -1463879.166% |
| LadRx Corporation | -2.03 Million USD | 27152.216% |
| Cell Source, Inc. | 9.23 Million USD | -5867.415% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | 2699580.596% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -86634.67% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -86634.67% |
| NovAccess Global Inc. | 2.17 Million USD | -25188.908% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -7691.15% |
| Itoco Inc. | 228.3 Thousand USD | -241204.395% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | -405013.649% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | -11013.778% |
| Kadimastem Ltd | -253.1 Thousand USD | 217763.235% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -136993.784% |
| CytoDyn Inc. | 20.26 Million USD | -2618.932% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | 85148477.125% |
| Mobile Lads Corp. | 484.23 Thousand USD | -113669.846% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | 5944098.602% |
| Qrons Inc. | 351.42 Thousand USD | -156663.709% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | -7049.103% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | 220799.463% |
| Rebus Holdings, Inc. | 305 Thousand USD | -180526.23% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | -12260.495% |
| International Stem Cell Corporation | 2.59 Million USD | -21170.656% |
| Bioxytran, Inc. | 1.89 Million USD | -28911.846% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -882584.697% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -25160.672% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 3.43 Million USD | -15942.807% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | -6341.132% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 772.6 Thousand USD | -71205.334% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | 44172.8% |
| Neutra Corp. | 52.18 Thousand USD | -1055546.042% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | 22233.789% |
| PureTech Health plc | -167.19 Million USD | 429.498% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | 225045.694% |
| IXICO plc | -4.44 Million USD | 12495.077% |
| IntelGenx Technologies Corp. | 13.21 Million USD | -4067.562% |
| Gelesis Holdings, Inc. | 54.85 Million USD | -904.375% |
| CSL Limited | 10.52 Billion USD | 94.766% |
| Cellectis S.A. | -43.81 Million USD | 1357.244% |